FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Proliferation topics
Proliferation
Cell Proliferation
Differentiation
Cancer Cell
Antibodies
Progesterone
Specificity
Cancer Cells
Antimicrobial
Lymphocyte
Cell Differentiation
Homogeneous
Amino Acids
Wound Healing
Epithelial

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Proliferation patents



      
           
This page is updated frequently with new Proliferation-related patent applications. Subscribe to the Proliferation RSS feed to automatically get the update: related Proliferation RSS feeds. RSS updates for this page: Proliferation RSS RSS


Device for ear drum repair

Device for ear drum repair

Date/App# patent app List of recent Proliferation-related patents
10/09/14
20140304093
 Method and system to promote sales or services with social sales point patent thumbnailMethod and system to promote sales or services with social sales point
The present disclosure is directed towards small modules, web plugins, which may be placed on any influential content which simplify and promote sales by operating as a social sales point (ssp). Ssp's simplify sales by avoiding buyers engaging in any further searches or product comparisons.
10/09/14
20140303727
 Device for ear drum repair patent thumbnailDevice for ear drum repair
A device for use in the repair of an ear drum in a subject in need of such treatment, said device: having a tensile strength youngs modulus between approximately 12.5 and 40 mpa; comprising one or more membrane layers, wherein at least one membrane layer comprises a plurality of pores; and wherein the device can support proliferation, migration and/or adhesion of cells selected from the group comprising at least any one or more of: keratinocytes, fibroblasts, vascular cells, mucosal epithelial cells, and stem cells.. .
10/09/14
20140303212
 Method for treating neurodegeneration using a p38mapk inhibitor patent thumbnailMethod for treating neurodegeneration using a p38mapk inhibitor
Ataxia-telangiectasia (a-t) is a progressive degenerative disorder that results in major neurological disability. In a-t patients, necropsy has revealed atrophy of all cerebellar cortical layers with extensive purkinje and granular cell loss.
10/09/14
20140303197
 Methods of treating and preventing leukemia and other cancers of the blood and bone patent thumbnailMethods of treating and preventing leukemia and other cancers of the blood and bone
The present invention relates to preventing and treating leukemia and other cancers of the blood and bone, as well as disorders of the blood, by inhibiting gut-derived serotonin. The inhibition of the gut-derived serotonin is accomplished by inhibiting tph1, an enzyme responsible for the production of gut-derived serotonin.
10/09/14
20140303162
 Azabicyclo compound and salt thereof patent thumbnailAzabicyclo compound and salt thereof
It is intended to provide a novel azabicyclo compound which exhibits both hsp90 inhibitory activity and cell proliferation inhibitory effect. Specifically disclosed is a compound represented by the following general formula (i) or a salt thereof: wherein x1 represents ch or n; any one of x2, x3 and x4 represents n, and the others represent ch; any one or two of y1, y2, y3 and y4 represent c—r4, and the others are the same or different and represent ch or n; r1 represents an optionally substituted monocyclic or bicyclic unsaturated heterocyclic group having 1 to 4 heteroatoms selected from n, s and o; r2 represents an alkyl group having 1 to 6 carbon atoms, or the like; and r3 and r4 represent —co—r5 or the like..
10/09/14
20140303111
 Compositions including triciribine and taxanes and methods of use thereof patent thumbnailCompositions including triciribine and taxanes and methods of use thereof
This application relates to combination therapies including triciribine and related compounds and taxanes and compositions with reduced toxicity thr the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.. .
10/09/14
20140303078
 Modulation of pancreatic beta cell proliferation patent thumbnailModulation of pancreatic beta cell proliferation
Work described herein provides, in one embodiment, a method for increasing proliferation or replication of pancreatic beta cells in a subject in need thereof, comprising administering to said subject an effective amount of an agent that increases the level or activity of hepatocellular carcinoma-associated protein td26 (td26), thereby increasing proliferation or replication of pancreatic beta cells. Such an agent may function by, for example, increasing the level of active td26 in the subject or by increasing the functional activity of td26 in the subject..
10/09/14
20140302491
 Ex vivo culture, proliferation and expansion of primary tissue organoids patent thumbnailEx vivo culture, proliferation and expansion of primary tissue organoids
Culture systems and methods for long term culture of mammalian tissues are provided. Tissues include but are not limited to lung alveolar tissue, stomach tissue, pancreas tissue, bladder tissue, liver tissue, and kidney tissue.
10/09/14
20140302057
 Inhibitors of metastasis patent thumbnailInhibitors of metastasis
The present invention relates to methods and compounds for treating or preventing cancer. Methods and compositions provided include including inhibiting or suppressing the development, maintenance, and proliferation of cancers, including blocking or inhibiting cancer cell metastasis..
10/09/14
20140302011
 Compositions including triciribine and trastuzumab and methods of use thereof patent thumbnailCompositions including triciribine and trastuzumab and methods of use thereof
This application relates to combination therapies including triciribine and related compounds and trastuzumab or a salt thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.. .
10/09/14
20140301943
Induction of thyroid iodide-handling gene expression in human cancers
Dual suppression of the map kinase and pi3k/akt pathways showed synergistic or greatly enhanced anti-melanoma cell effects, compared to suppression of a single pathway, including the inhibition of cell proliferation, transformation and invasion, induction of g0/g1 cell cycle arrest and, importantly, cell apoptosis. Remarkably, suppression of either pathway induces the expression of thyroid iodide-handling genes and dual suppression of the two pathways synergistically and robustly induces expression of these genes, accompanied by uptake of radioiodine in the cells.
10/02/14
20140296344
Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
There are provided various polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds can be useful as cancer chemopreventive agents, cancer treating agent, inhibiting tumor growth or cell proliferation, reducing tumor growth or as radioenhencers for radiotherapy of cancer..
10/02/14
20140296312
Treatment of breast cancer
The disclosure describes the use of one or more compounds that fall within the scope of one or more of structural formulae i, ii, iii, iv, v, or vi for treating triple negative breast compounds useful for treating breast cancer include those compounds of formulae i, ii, iii, iv, v, or vi that inhibit proliferation of breast cancer cells and/or lead to the death of breast cancer cells, especially triple negative breast cancer.. .
10/02/14
20140296307
Potent analogues of the c-myc inhibitor 10074-g5 with improved cell permeability
The present invention relates compounds and compositions for interfering with the association of myc and max. These compounds and compositions are useful in methods for inhibiting growth or proliferation of a cell.
10/02/14
20140296230
Dihydroquinazolinone analogues
Wherein the groups r1 to r4 and a1 to a5 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament..
10/02/14
20140296229
Indolinone analogues
Wherein the groups r1 to r4, a1 and a2 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament..
10/02/14
20140296156
Peptide based inhibition of capcna interaction in cancer
Peptides derived from cancer specific isoform of proliferating cell nuclear antigen (capcna, also known as cspcna) or from nmpcna-interacting proteins interfere with intracellular protein-protein interaction, thereby causing a reduction in the proliferative potential of cancer. These peptides serve as therapeutic compositions to reduce the proliferation of cancer cells and also augment existing chemotherapeutic methods..
10/02/14
20140296143
Angiotensin-(1-7) as a chemoprevention agent
Disclosed is the use of angiotensin-(1-7) peptide as an anti-cancer and chemoprevention therapeutic. Embodiments of the present invention comprise methods and compositions to prevent cancer or to reduce the risk of cancer in an individual comprising administering to the individual a pharmaceutically effective amount of an agonist for the angiotensin-(1-7) receptor to inhibit at least one of formation of a tumor (tumorigenesis), the proliferation of tumor cells, the growth of tumor cells, or metastasis of tumor cells in the individual.
10/02/14
20140296104
Genes differentially expressed by cumulus cells and assays using same to identify pregnancy competent oocytes
A genetic means of identifying “pregnancy competent” oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes.
10/02/14
20140295414
Methods and compositions for labeling nucleic acids
The present invention relates to methods for the labeling of nucleic acid polymers in vitro and in vivo. In particular, the methods include a [3+2] cycloaddition between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent attached to a label.
10/02/14
20140294971
Cancer cell-inhibiting ceramic, process for producing cancer cell-inhibiting ceramic, method for treating bone tumor, and use of beta-tricalcium phosphate porous granules with particle size of 1 to 10 micrometer
Proliferation of cancer cells is effectively inhibited. Provided is a cancer cell-inhibiting ceramic containing a β-tricalcium phosphate porous granule with a particle size of 1 to 10 μm.
10/02/14
20140294957
Niclosamide for the treatment of cancer metastasis
The invention relates to niclosamide and derivates thereof, which effectively inhibit transcription of the s100a4 gene, resulting in inhibition and/or reduction of s100a4-induced cell motility, invasiveness, metastasis and proliferation of human cancer cells.. .
10/02/14
20140294931
Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
Thyroid hormone antagonists and their nanoparticle formulations (nanotetrac™ or nanotriac™) act at a cell surface receptor to block angiogenesis and tumor cell proliferation. The complex anti-angiogenic performs actions on specific cytokines and chemokines.
10/02/14
20140294912
Amorphous poly(d,l-lactide) coating
Implantable devices formed of or coated with a material that includes an amorphous poly(d,l-lactide) formed of a starting material such as meso-d,l-lactide are provided. The implantable device can be used for the treatment, mitigation, prevention, or inhibition of a disorder such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, patent foramen ovale, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof..
10/02/14
20140294897
Potent lna oligonucleotides for the inhibition of hif-1a expression
The present disclosure relates to an lna oligonucleotide consisting of a sequence selected from the group consisting of 5′-(tx)gxgxcsasasgscsastscscstxgxt-3′ and 5′-(gx)txtxascstsgscscststscstxtxa-3′, wherein capital letters designate a beta-d-oxy-lna nucleotide analogue, small letters designate a 2-deoxynucleotide, underline designates either a beta-d-oxy-lna nucleotide analogue or a 2-deoxynucleotide, subscript “s” designates a phosphorothioate link between neighbouring nucleotides/lna nucleotide analogues, and subscript “x” designates either a phosphorothioate link or a phosphorodiester link between neighbouring nucleotides/lna nucleotide analogues, and wherein the sequence is optionally extended by up to five 2-deoxynucleotide units. The lna oligonucleotides are useful for modulating the expression of hypoxia-inducible factor-1a (hif-1a), e.g.
10/02/14
20140294855
Small molecule screening for mouse satellite cell proliferation
The invention provides methods for inducing, enhancing or increasing satellite cell proliferation, and an assay for screening for a candidate compound for inducing, enhancing or increasing satellite cell proliferation. Also provided is a method for repairing or regenerating a damaged muscle tissue of a subject..
09/25/14
20140288178
Inhibition of c-myc ubiquitination to prevent cancer initiation and progression
The present invention is directed to methods of inhibiting cancer cell proliferation, differentiation and/or survival. These methods involve the administration of fbw7 e3 ligase inhibitors to inhibit c-myc ubiquitination in cancerous cell populations, such as leukemic initiating cell populations, that are responsible for disease initiation and progression..
09/25/14
20140288162
Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma
Methods and compositions are provided for treating human synovial sarcoma (ss). Also provided are screens to identify therapeutics for the treatment of synovial sarcoma.
09/25/14
20140288142
Nitric oxide donor compounds
The invention relates to nitric oxide donor compounds and their use for treating cardiovascular diseases, inflammation, pain, fever, gastrointestinal disorders, ophthalmic diseases, hepatic disorders, renal diseases, respiratory disorders, immunological diseases, bone metobolisms dysfunctions, central and peripheral nervous system diseases, sexual dysfunctions, infectious diseases, for the inhibition of platelet aggregation and platelet adhesion, for treating pathological conditions resulting from abnormal cell proliferation, vascular diseases. The invention also relates to compositions comprising at least one nitric oxide releasing compounds of the invention and composition comprising at least one nitric oxide releasing compounds according to the invention and at least one 15 therapeutic agent..
09/25/14
20140288070
Compounds and methods for kinase modulation, and indications therefor
Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on at least one raf protein kinase.
09/25/14
20140288032
Agents and devices for use in prevention of restenosis
Agents that inhibit or prevent restenosis are identified by assaying test agents in a battery of assays to measure the effect of the test agent on cell proliferation, thrombosis, tissue modeling, and inflammation. Treatment for restenosis is provided using compositions of the invention..
09/25/14
20140287432
Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation
The present invention relates to methods for the diagnosis, prevention and treatment of heart disease or heart failure in a subject. The present invention also relates to methods for the diagnosis, prevention and treatment of atherosclerosis with vulnerable plaque in a subject.
09/25/14
20140287018
Nanoparticle-based scaffolds and implants, methods for making the same, and applications thereof
Implant-associated bacterial infections are one of the most serious complications in orthopedic surgery. Treatment of these infections often requires multiple operations, device removal, long-term systemic antibiotics, and extended rehabilitation, and is frequently ineffective, leading to worse clinical outcomes and increased financial costs.
09/25/14
20140287000
Tumor proliferation inhibitor containing ultrasound-sensitive substance and method for inhibiting tumor proliferation by using tumor proliferation inhibitor and low-intensity pulsed ultrasound waves
Provided are a tumor proliferation inhibitor and a method for inhibiting tumor proliferation both of which can be applied to a minimally invasive cancer treatment using low-intensity pulsed ultrasound. The present invention provides a tumor proliferation inhibitor containing an ultrasound-sensitive substance and an acoustic cavitation phenomenon-enhancing substance, and provides a method for inhibiting tumor proliferation that can exhibit a tumor proliferation-inhibitory effect using the tumor proliferation inhibitor in combination with low-intensity pulsed ultrasound of a degree that is used in ultrasound diagnosis, and that can be applied to a minimally invasive cancer treatment using low-intensity pulsed ultrasound..
09/25/14
20140286987
Methods for controlling t cell proliferation
The technology relates generally to the field of immunology and relates in part to compositions and methods for controlling the proliferation of t cells, for example, therapeutic t cells. The methods further relate to compositions and methods for inducing an immune response in a subject..
09/25/14
20140286910
Stem cells and methods incorporating environmental factors as a means for enhancing stem cell proliferation and plasticity
Therapeutic stem cells and methods for their use and manufacture. Stem cells are produced under conditions in which the stem cells are exposed to at least one environmental factor, including decreased oxygen tension.
09/18/14
20140277293
Methods for in vitro inhibition of fibroblast proliferation
Methods for led generated low-level light therapy (lllt) in the red, blue, and ir ranges are described to effectively inhibit fibroblast proliferation in vitro without altering viability, and may be used as therapy for the treatment of scars and other proliferative skin diseases.. .
09/18/14
20140275235
Treatment of proliferative disorders
The present invention relates to a method and composition for treating safely (in a non-toxic way) disease or disorder exhibiting excessive cellular proliferation comprising administering to a patient needing such treatment, a composition comprising curcumin (derived from turmeric), epigallocatechin-3-gallate (egcg, enriched in green tea), glucosinolates (enriched in cruciferous vegetables) and/or derivatives thereof, such as sulforaphane (sfn), alone or combined with a ketogenic diet or a modified ketogenic diet. Also the current invention relates to a composition comprising medium chain triglycerides, epigallocatechin-3-gallate, curcumin, compositions comprising glucosinolates and/or derivatives thereof, such as sulforaphane (sfn).
09/18/14
20140275165
Compounds that inhibit nfkb and bace1 activity
The present invention relates to compounds with activity as bace1 and nfκb modulators, and methods for treating, preventing, or ameliorating neurodegenerative diseases, such as alzheimer's disease. The present invention is also directed to the treatment of diseases related to dysfunction of cell proliferation, the immune system and/or inflammation using such compounds or pharmaceutical compositions containing such candidate compounds..
09/18/14
20140275162
Inhibition of leukotriene synthesis and activity in the treatment of sonic hedgehog-associated medulloblastoma
Treating sonic hedgehog-associated medulloblastoma comprises inhibiting the synthesis or biologic activity of leukotrienes that drive nestin expression in cancerous or precancerous granule neuron precursors and that further drive growth and proliferation of medulloblastoma cells through nestin-mediated aberrant sonic hedgehog signaling.. .
09/18/14
20140275083
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
Or a pharmaceutically acceptable salt thereof, wherein r1, r2a, r2b and r3-r7 are herein. The invention is also directed to compositions containing a compound of formula (i) and to the use of such compounds in the inhibition of mutant idh proteins having a neomorphic activity.


Popular terms: [SEARCH]

Proliferation topics: Proliferation, Cell Proliferation, Differentiation, Cancer Cell, Antibodies, Progesterone, Specificity, Cancer Cells, Antimicrobial, Lymphocyte, Cell Differentiation, Homogeneous, Amino Acids, Wound Healing, Epithelial

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Proliferation for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Proliferation with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



1.1178

3792

3 - 0 - 75